P7_TA(2011)0039 Tuberculosis Vaccine Initiative (TBVI) B7-0075 , 0076 and 0089/2011 European Parliament resolution of 3 February 2011 on the Tuberculosis Vaccine Initiative (TBVI) – practical implementation of the Europe 2020 strategy with a view to meeting MDG 6 and eliminating tuberculosis by 2050 The European Parliament , – having regard to the United Nations Millennium Development Goals (MDGs), which provide for halting the increase in the incidence of tuberculosis by 2015 and reversing the trend, – having regard to the Tuberculosis Vaccine Initiative (TBVI), an independent, not-for-profit organisation, the only pan-European organisation of its type, set up with Commission backing, which supports the urgent development of new vaccines and facilitates and brings its experience to an integrated European network, – having regard to the Lisbon Strategy, which seeks to establish a European research and innovation area, the Europe of Innovation initiative and the Europe 2020 strategy flagship initiative on an Innovation Union, – having regard to the Stop Tuberculosis programme, under the aegis of the WHO, which has set itself the goal of a 50% reduction in the tuberculosis prevalence and mortality rates, from a 1990 baseline, by 2015 and eliminating the disease by 2050, – having regard to the WHO report (WHO/HTM/TB/2010.3) entitled ‘Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response’, on the worrying emergence of strains of tuberculosis resistant or highly resistant to treatment, – having regard to the Berlin Declaration on Tuberculosis at the WHO European Ministerial Forum of 22 October 2007, entitled ‘All Against Tuberculosis’ (EUR/07/5061622/5, 74415), – having regard to the report of the European Academies' Science Advisory Council, which found that the cost of tuberculosis treatment alone in the EU was EUR 2 billion a year (EASAC Policy Report 10, March 2009, ISBN: 9789-0-85403-746-9), – having regard to the meeting of the Global Fund to Fight AIDS, Tuberculosis and Malaria in New York in October 2010, – having regard to its resolution of 7 October 2010 on health care systems in sub-Saharan Africa and global health Texts adopted, P7_TA(2010)0355 . , – having regard to Rules 115(5) and 110(4) of its Rules of Procedure, A. whereas access to health care is a right recognised in the Universal Declaration of Human Rights, and governments must meet their obligation to provide public health services to their entire population, B. whereas medicines cannot be treated as purely commercial products, C. whereas, with